Eidos Therapeutics Inc
EIDX · Other · NASDAQ · in our data June 20, 2018 to January 25, 2021 (2.6 years)
The first trading day in our data for Eidos Therapeutics Inc is June 20, 2018 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on December 31, 2020, the market valued it at $5.1 billion. It left the market when it was bought or merged, last trading at $122.21, -7.1% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2018. How these numbers are made · Report a data issue.
Could you have seen it coming? Play Meme ManiaAlso gone in 2021: Other
- P P D Inc peaked at $16.7 billion
- Pluralsight Inc peaked at $3.4 billion
- Translate Bio Inc peaked at $2.9 billion
- Constellation Pharmctcl peaked at $2.1 billion
- Amerant Bancorp Inc peaked at $1.1 billion
- Prevail Therapeutics Inc peaked at $795 million
